The only known measure for prevention of<unk>  is the non-use or cautious use of GBCAs in patients with renal impairment, including preferential use of safer, macrocyclic GBCAs. Performing dialysis immediately after the MRI exam is recommended for patients already in dialysis treatment, but there is no evidence for introducing dialysis in non-dialytic patients for prevention of<unk> . Screening for impaired kidney function is routinely conducted and has drastically reduced the incidence of<unk> .
Nephrogenic systemic fibrosis
Goodpasture syndrome
HIV-associated nephropathy
Eosinophilic granulomatosis with polyangiitis
Granulomatosis with polyangiitis
Thin basement membrane disease
Mixed connective tissue disease
IgA vasculitis